International Journal on Science and Technology
E-ISSN: 2229-7677
•
Impact Factor: 9.88
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 16 Issue 4
October-December 2025
Indexing Partners
Evaluation of Homocysteine, D-dimer and Biochemical Parameters in Relation to Chronic Kidney Disease Stages among Patients Attending Specialist Hospitals in Enugu, Enugu State.
| Author(s) | Linda Nnenna Ogbonna, Silas Anayo Ufelle, Cyril Okonkwo Ogbonna, Dickson Obinna Nwodo, Gatuwa Aglavdawa |
|---|---|
| Country | Nigeria |
| Abstract | Abstract Background of the study: Chronic kidney disease is a major health challenge ravaging the world due to its progressive irreversible effect. The related morbidity and mortality poses a great concern to developing countries like Nigeria owing to the clinically silent onset of the disease and the underlying co-morbidities. People with chronic kidney disease are predisposed to various biochemical and fibrinolytic alterations arising due to immune activation and endothelial dysfunction thereby exposing them to thrombotic events. Aim: The aim of the study was to evaluate the homocysteine, D-dimer and biochemical parameters in relation to chronic kidney disease stages among patients attending specialist hospitals in Enugu, Enugu State. Methodology: The study adopted a cross sectional research design. A total of one hundred and eighty consented participants comprising of one hundred diagnosed chronic kidney disease patients and eighty apparently healthy age and sex matched controls within 18-65 years from Enugu State University Teaching Hospital, Parklane and University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu were recruited for this study. Ethical approval was obtained and demographic data were obtained using a well-structured questionnaire. Serum electrolyte was assayed using Exias biochemical autoanalyzer while urea and creatinine was determined using Cobas 111 autoanalyzer. Quantitative evaluation of homocysteine and D-dimer levels were done using enzyme linked immunosorbent assay (ELISA) technique. Results: Kidney function and electrolytes test of people with chronic kidney disease showed a significant increase (p < 0.05) in urea (16.47±1.794 mmol/l) and creatinine (497.19±42.081 µmol/l) as compared to the controls (4.04±0.855 mmol/l) and (94.24±20.236 µmol/l) respectively. There was a significant decrease (p < 0.05) in sodium (133.44±15.652 mmol/l), chloride (100.44±6.321 mmol/l) and bicarbonate (22.16±2.638 mmol/l) as compared to the controls (139.41±4.371 mmol/l), (104.92±3.785 mmol/l) and (23.38±3.18 mmol/l) respectively. The logistic regression analysis of biochemical parameters with chronic kidney disease stages revealed urea and creatinine as the predictors of chronic kidney disease. Homocysteine levels were significantly increased (P < 0.05) among people with chronic kidney disease (18.20±3.64 µmol/l) as compared to the controls (8.85±2.96 µmol/l). It also revealed a significant systematic increase (P < 0.05) across chronic kidney disease stages 3 (17.14±3.14 µmol/l), stage 4 (17.24±3.18 µmol/l) and stage 5 (19.40±3.86 µmol/l) respectively. D-dimer levels was significantly increased (P < 0.05) among chronic kidney disease patients (10690.02±143.26 ng/ml) as compared to the controls (370.78±253.34 ng/ml). D-dimer also showed a significant progressive increase (P < 0.05) across the chronic kidney disease stages (1017.95±98.97ng/ml), (1063.59±197.85 ng/ml) and (1103.18±121.22 ng/ml) respectively. Conclusion: This study demonstrated that chronic kidney disease patients exhibit serious alterations in the electrolytes, urea, creatinine, homocysteine and D-dimer levels making them potential biomarkers of chronic kidney disease. Therefore, their investigations serves as competent measure of differential diagnosis. |
| Keywords | CKD Chronic Kidney Disease, eGFR estimated glomerular filtration rate, ESRD end stage renal disease, HCy homocysteine |
| Field | Medical / Pharmacy |
| Published In | Volume 16, Issue 4, October-December 2025 |
| Published On | 2025-12-06 |
| DOI | https://doi.org/10.71097/IJSAT.v16.i4.9817 |
| Short DOI | https://doi.org/hbf83z |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJSAT DOI prefix is
10.71097/IJSAT
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.